Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

19 Jun 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Binimetinib Tablets, 45 mg. It has enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1802.80
Dr. Reddys Labs. 1355.15
Cipla 1377.50
Lupin 2011.20
Zydus Lifesciences 1235.90
View more..